1. Analysis of change from baseline between treatment and placebo for change in lesion volume (LV) at month 12 for REC-994 200 mg (p=0.987) and REC-994 400 mg (p-0.449) assessed by mixed model for repeated measures( MMRM) analysis
1. Analysis of change from baseline between treatment and placebo for change in lesion volume (LV) at month 12 for REC-994 200 mg (p=0.987) and REC-994 400 mg (p-0.449) assessed by mixed model for repeated measures( MMRM) analysis